Compounds > carbocysteine-lysine
Page last updated: 2024-09-04

carbocysteine-lysine and 8-epi-prostaglandin f2alpha

carbocysteine-lysine has been researched along with 8-epi-prostaglandin f2alpha in 1 studies

Compound Research Comparison

Studies
(carbocysteine-lysine)		Trials
(carbocysteine-lysine)		Recent Studies (post-2010)
(carbocysteine-lysine)		Studies
(8-epi-prostaglandin f2alpha)		Trials
(8-epi-prostaglandin f2alpha)		Recent Studies (post-2010) (8-epi-prostaglandin f2alpha)
19531,863248723

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carpagnano, GE; Di Gioia, G; Foschino-Barbaro, MP; Gramiccioni, E; Resta, O; Serviddio, G; Spanevello, A; Stefano, A1

Trials

1 trial(s) available for carbocysteine-lysine and 8-epi-prostaglandin f2alpha

ArticleYear
Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys).
    European journal of pharmacology, 2004, Nov-28, Volume: 505, Issue:1-3

    Topics: Adult; Carbocysteine; Dinoprost; Exhalation; Female; Humans; Interleukin-6; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Respiratory Function Tests; Time Factors; Treatment Outcome

2004